C-peptide is cleaved from proinsulin and released in equal amounts with insulin. In diseases affecting insulin levels, C-peptide changes often reflect insulin alterations. Both insulin and C-peptide levels can increase in conditions like renal failure and insulinomas. However, discordant levels are seen in cases of exogenous insulin use or the presence of anti-insulin antibodies.